Vaxzevria® (COVID-19 Vaccine AstraZeneca)

The European Medicines Agency authorised the use of the Vaxzevria® (COVID-19 Vaccine AstraZeneca) in January 2021. 

This page contains information to support vaccinators who are administering the Vaxzevria® (COVID-19 Vaccine AstraZeneca).

AstraZeneca Summary Sheet

Materials for Vaccinators

Please note if you are using TrackVax Vaccine Reconciliation should be done through this system instead. 

Information from the European Medicines Agency

Information from the World Health Organization

Go to the COVID-19 Page for Health Professionals

This page was updated on 8 October 2021